Literature Search

HomeLiterature Search

Popular searches

TP53 BRCA1 CRISPR single-cell cancer

Hellewell(P G),Williams(T J) Br J Pharmacol 1989-07-05

1. Eight platelet activating factor (Paf) antagonists were evaluated as inhibitors of oedema formation in rabbit skin in...

Sachs(L) Cult Med Psychiatry 1989-10-23

In this paper I want to draw attention to the integration of Western medicine into therapeutic choices among patients in...

Askew(I) Stud Fam Plann 1989-09-28

"Community participation" is a popular phrase with policymakers but the operational implications of putting the idea int...

Nordstrom(C R) Soc Sci Med 1989-06-05

Ayurveda, in practice, comprises far more than a medical tradition in Sri Lanka. It provides, in addition to a manuscrip...

Tolins(J P),Vercellotti(G M),Wilkowske(M),Ha… J Lab Clin Med 1989-04-24

We have developed a model of endotoxemic acute renal failure in the anesthetized male rat in which acute endotoxin infus...

Shukla(S D),Morrison(W J),Dhar(A) Mol Pharmacol 1989-05-23

Treatment of 32P-labeled rabbit platelets with platelet-activating factor (PAF) caused a time- and dose-dependent phosph...

Basnayake(S),Thapa(S),Balogh(S A) Stud Fam Plann 1988-06-02

This paper presents findings based on a one-year pre-introductory clinical investigation concerning safety, efficacy, an...

Snowden(R),Kennedy(K I),Leon(F),Orense(V C),… Stud Fam Plann 1988-11-21

A study of the knowledge, perceptions, and behavioral intentions of physicians regarding periodic abstinence (PA) method...

Neuwirth(R),Singhal(P),Satriano(J A),Braquet… J Pharmacol Exp Ther 1988-01-04

Platelet activating factor (PAF; 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is a lipid mediator of inflammation produ...

Rubin(R M),Samples(J R),Rosenbaum(J T) Arch Ophthalmol 1988-09-01

Platelet-activating factor (PAF), a lipid mediator of inflammation, may markedly increase vascular permeability. We asse...

Previous 889 890 891 892 893 894 895 896 897 Next Vol. 893 / of 981 页